Skip to main content

Table 1 Patient characteristics

From: Novel double-filtration plasmapheresis preserves fibrinogen while removing immunoglobulin-G antibodies before ABO blood type-incompatible kidney transplantation

  cDFPP (n = 23) nDFPP (n = 12) p value
Original Disease IgAN 5 4 .676#
CGN 6 0
ADPKD 5 4
DM 2 1
Unknown or Others 5 3
Duration of pre-transplant dialysis (years) 0.5 (0.0–14.1) 1.2 (0.0–14.2) .856$
Sex (male:female) 15:8 3:7 .469#
Age at transplant (years) 51 (14–68) 61 (26–67) .022$
Height (cm) 161.5 (150.1–180.0) 160.0 (148.0–179.5) .790$
Weight (kg) 59.15 (37.7–78.0) 57.53 (43.75–73.90) .348$
Body mass index 21.2 (16.0–27.7) 23.3 (16.7–26.7) .099$
Pre-DFPP data Hematocrit (%) 34.2 (23.3–47.8) 31.3 (23.3–36.9) .215$
Total protein (mg/dL) 6.4 (4.9–7.1) 6.2 (5.5–6.6) .278$
Albumin (mg/dL) 3.6 (3.0–4.3) 3.5 (3.3–3.8) .517$
Total IgG (mg/dL) 905 (351–1884) 1011 (585–1463) .948$
Platelet count (/µL) 17.8 (11.4–37.3) 18.6 (11.6–28.4) .824$
PT-INR 0.98 (0.82–1.20) 1.02 (0.94–1.30) .179$
APTT (s) 28.1 (23.7–39.6) 29.3 (26.0–42.6) .840$
Total IgM (mg/dL) 83 (21–220) 54 (21–162) .122$
Fibrinogen (mg/dL) 224 (129–304) 381 (222–471) .001$
Anti-ABO IgG antibody titer 1:16 (1:4–1:512) 1:32 (1:8–1:1024) .493$
Anti-ABO IgM antibody titer 1:32 (1:8–1:128) 1:12 (1:4–1:16) .001$
  1. ADPKD Autosomal-dominant polycystic kidney disease, APTT activated partial thromboplastin time, CGN chronic glomerulonephritis, DM diabetes mellitus, IgAN IgA nephropathy, PT-INR international normalized ratio of prothrombin time. #: chi-squared test, $: Wilcoxon rank-sum test